| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| BUY | SELL | NEUTRAL | BUY | BUY |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 2.04▲ | 2.05▲ | 2.06▼ | 2.03▲ | 1.74▲ |
| MA10 | 2.03▲ | 2.07▼ | 2.06▼ | 1.88▲ | 1.78▲ |
| MA20 | 2.04▲ | 2.05▼ | 2.08▼ | 1.74▲ | 1.66▲ |
| MA50 | 2.06▼ | 2.06▼ | 1.95▲ | 1.75▲ | 1.77▲ |
| MA100 | 2.05▲ | 1.94▲ | 1.81▲ | 1.65▲ | 1.89▲ |
| MA200 | 2.08▼ | 1.80▲ | 1.73▲ | 1.72▲ | 2.63▼ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | 0.001▲ | -0.004▼ | -0.013▼ | 0.050▲ | 0.040▲ |
| RSI | 51.820▲ | 48.319▼ | 52.625▲ | 64.811▲ | 59.844▲ |
| STOCH | 25.000 | 24.791 | 70.635 | 70.709 | 39.163 |
| WILL %R | 0.000▲ | -66.667 | -35.714 | -30.435 | -24.419▲ |
| CCI | 77.051 | -134.878▼ | -14.565 | 108.584▲ | 152.743▲ |
|
Tuesday, January 13, 2026 04:00 PM
Fintel reports that on January 21, 2026, B of A Securities initiated coverage of Inhibikase Therapeutics (NasdaqCM:IKT) with a Buy recommendation. As of January 14, 2026, the average one-year price ...
|
|
Cantor Fitzgerald Initiates Coverage of Inhibikase Therapeutics (IKT) with Overweight Recommendation
Thursday, December 04, 2025 04:00 PM
Fintel reports that on December 11, 2025, Cantor Fitzgerald initiated coverage of Inhibikase Therapeutics (NasdaqCM:IKT) with a Overweight recommendation. As of December 5, 2025, the average one-year ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 27/02/26 | 2.07 | 2.10 | 2.025 | 2.05 | 1,260,917 |
| 26/02/26 | 2.14 | 2.14 | 1.95 | 2.09 | 2,468,661 |
| 25/02/26 | 2.05 | 2.26 | 2.03 | 2.14 | 2,880,788 |
| 24/02/26 | 1.83 | 2.06 | 1.80 | 2.05 | 4,019,334 |
| 23/02/26 | 1.98 | 2.11 | 1.75 | 1.80 | 0 |
| 20/02/26 | 1.74 | 1.77 | 1.70 | 1.76 | 673,731 |
| 19/02/26 | 1.79 | 1.805 | 1.74 | 1.74 | 472,871 |
| 18/02/26 | 1.71 | 1.83 | 1.69 | 1.80 | 1,003,701 |
| 17/02/26 | 1.67 | 1.72 | 1.65 | 1.69 | 542,504 |
| 13/02/26 | 1.64 | 1.725 | 1.64 | 1.67 | 225,762 |
|
|
||||
|
|
||||
|
|